146 related articles for article (PubMed ID: 30199481)
1. Invasive Candidiasis in Pediatric Intensive Care Unit: More Challenges.
Pana ZD; Kotzadamis D; Roilides E
Pediatr Infect Dis J; 2018 Dec; 37(12):1309-1311. PubMed ID: 30199481
[No Abstract] [Full Text] [Related]
2. Invasive Fungal Infections in the Pediatric Intensive Care Unit.
Mantadakis E; Tragiannidis A
Pediatr Infect Dis J; 2019 Sep; 38(9):e216-e218. PubMed ID: 31261360
[No Abstract] [Full Text] [Related]
3. Invasive fungal infections in the pediatric population.
Lehrnbecher T; Groll AH
Expert Rev Anti Infect Ther; 2011 Mar; 9(3):275-8. PubMed ID: 21417864
[No Abstract] [Full Text] [Related]
4. Pediatric invasive fungal infections: realities, challenges, concerns, myths and hopes.
Dinleyici EC
Expert Rev Anti Infect Ther; 2011 Mar; 9(3):273-4. PubMed ID: 21417863
[No Abstract] [Full Text] [Related]
5. Risk factors for fluconazole-resistant invasive candidiasis in intensive care unit patients: An analysis from the China Survey of Candidiasis study.
Liao X; Qiu H; Li R; Guo F; Liu W; Kang M; Kang Y;
J Crit Care; 2015 Aug; 30(4):862.e1-5. PubMed ID: 26002430
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the incidence, clinical features and outcomes of invasive candidiasis in children and neonates.
Hsu JF; Lai MY; Lee CW; Chu SM; Wu IH; Huang HR; Lee IT; Chiang MC; Fu RH; Tsai MH
BMC Infect Dis; 2018 Apr; 18(1):194. PubMed ID: 29699503
[TBL] [Abstract][Full Text] [Related]
7. Invasive candidiasis and the utility of antifungal susceptibility testing in the ICU.
Coyle EA
J Pharm Pract; 2010 Feb; 23(1):33-7. PubMed ID: 21507791
[TBL] [Abstract][Full Text] [Related]
8. Problematic Dichotomization of Risk for Intensive Care Unit (ICU)-Acquired Invasive Candidiasis: Results Using a Risk-Predictive Model to Categorize 3 Levels of Risk From a Multicenter Prospective Cohort of Australian ICU Patients.
Playford EG; Lipman J; Jones M; Lau AF; Kabir M; Chen SC; Marriott DJ; Seppelt I; Gottlieb T; Cheung W; Iredell JR; McBryde ES; Sorrell TC
Clin Infect Dis; 2016 Dec; 63(11):1463-1469. PubMed ID: 27601224
[TBL] [Abstract][Full Text] [Related]
9. Invasive Fungal Infections in the Intensive Care Unit.
Ostrosky-Zeichner L; Al-Obaidi M
Infect Dis Clin North Am; 2017 Sep; 31(3):475-487. PubMed ID: 28687215
[TBL] [Abstract][Full Text] [Related]
10. [Invasive candidiasis in neonatal intensive care units].
Brissaud O; Tandonnet O; Guichoux J
Arch Pediatr; 2011 May; 18 Suppl 1():S22-32. PubMed ID: 21596283
[TBL] [Abstract][Full Text] [Related]
11. An Italian consensus for invasive candidiasis management (ITALIC).
Scudeller L; Viscoli C; Menichetti F; del Bono V; Cristini F; Tascini C; Bassetti M; Viale P;
Infection; 2014 Apr; 42(2):263-79. PubMed ID: 24272916
[TBL] [Abstract][Full Text] [Related]
12. [Invasive candidiasis in critically ill adult patient].
Tobar A E; Silva O F; Olivares C R; Gaete G P; Luppi N M
Rev Chilena Infectol; 2011 Feb; 28(1):41-9. PubMed ID: 21526285
[TBL] [Abstract][Full Text] [Related]
13. Results from a prospective, international, epidemiologic study of invasive candidiasis in children and neonates.
Steinbach WJ; Roilides E; Berman D; Hoffman JA; Groll AH; Bin-Hussain I; Palazzi DL; Castagnola E; Halasa N; Velegraki A; Dvorak CC; Charkabarti A; Sung L; Danziger-Isakov L; Lachenauer C; Arrieta A; Knapp K; Abzug MJ; Ziebold C; Lehrnbecher T; Klingspor L; Warris A; Leckerman K; Martling T; Walsh TJ; Benjamin DK; Zaoutis TE;
Pediatr Infect Dis J; 2012 Dec; 31(12):1252-7. PubMed ID: 22982980
[TBL] [Abstract][Full Text] [Related]
14. Initial therapeutic strategy of invasive candidiasis for intensive care unit patients: a retrospective analysis from the China-SCAN study.
Cui N; Wang H; Su L; Qiu H; Li R; Liu D;
BMC Infect Dis; 2017 Jan; 17(1):93. PubMed ID: 28114898
[TBL] [Abstract][Full Text] [Related]
15. Drugs currently under investigation for the treatment of invasive candidiasis.
McCarthy MW; Walsh TJ
Expert Opin Investig Drugs; 2017 Jul; 26(7):825-831. PubMed ID: 28617137
[TBL] [Abstract][Full Text] [Related]
16. Echinocandins in Pediatric Invasive Candidiasis and the Challenges of Antifungal Use in Children.
Yeoh DK; Blyth CC; McMullan BJ
J Pediatric Infect Dis Soc; 2021 Aug; 10(7):755-756. PubMed ID: 34106257
[No Abstract] [Full Text] [Related]
17. [Invasive candidiasis in newborns: diagnosis, treatment and prophylaxis].
Izquierdo G; Santolaya ME
Rev Chilena Infectol; 2014 Feb; 31(1):73-83. PubMed ID: 24740778
[TBL] [Abstract][Full Text] [Related]
18. Cost and resource utilization associated with fluconazole as first-line therapy for invasive candidiasis: a retrospective database analysis.
Craver CW; Tarallo M; Roberts CS; Blanchette CM; Ernst FR
Clin Ther; 2010 Dec; 32(14):2467-77. PubMed ID: 21353115
[TBL] [Abstract][Full Text] [Related]
19. MSG-01: A randomized, double-blind, placebo-controlled trial of caspofungin prophylaxis followed by preemptive therapy for invasive candidiasis in high-risk adults in the critical care setting.
Ostrosky-Zeichner L; Shoham S; Vazquez J; Reboli A; Betts R; Barron MA; Schuster M; Judson MA; Revankar SG; Caeiro JP; Mangino JE; Mushatt D; Bedimo R; Freifeld A; Nguyen MH; Kauffman CA; Dismukes WE; Westfall AO; Deerman JB; Wood C; Sobel JD; Pappas PG
Clin Infect Dis; 2014 May; 58(9):1219-26. PubMed ID: 24550378
[TBL] [Abstract][Full Text] [Related]
20. [Current options for antifungal therapy of invasive candidiasis in intensive care units].
Hamal P; Raclavský V; Svobodová L; Koukalová D
Klin Mikrobiol Infekc Lek; 2010 Oct; 16(5):164-70. PubMed ID: 21191874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
